Madeira Therapeutics Names David Tousley to Board of Advisors (Centre Daily Times)
Madeira Therapeutics, a new drug-development company specializing in pediatric pharmaceuticals, is pleased to announce the addition of David L. Tousley, MBA, CPA, to the Madeira Board of Advisors. David Tousley is currently the Principal of Stratium Consulting Services, assisting companies with strategic and financial planning and management.
Read More.. and DISCUSS
Madeira Therapeutics, a new drug-development company specializing in pediatric pharmaceuticals, is pleased to announce the addition of David L. Tousley, MBA, CPA, to the Madeira Board of Advisors. David Tousley is currently the Principal of Stratium Consulting Services, assisting companies with strategic and financial planning and management.
Read More.. and DISCUSS